Weight gain fears from combining insulin and liraglutide quelledConcerns that the addition of insulin to type 2 diabetes patients already on the new injectable glucagon-like peptide (GLP-1) liraglutide could result in weight gain may not be warranted, researchers suggested here. New smoking cessation program in B.C.New PharmaCare program aimed at helping people cut out tobacco. 2011 Eye Care Supplement: Keeping an eye on cataracts Prevention, treatment and patient education. Edurant: a new NNRTI for HIV Rilpivirine is the fifth NNRTI to be marketed in Canada. Investigational diabetes drug from controversial class shows promise But Japanese patient population that was the subject of this study has different risk factors compared with other groups New antiretroviral agent added to HIV arsenal P.E.I. pharmacists in anti-smoking campaign Pharmacists’ association, Cancer Society link up for six-week anti-smoking campaign. Once-weekly exenatide no match for daily liraglutide in type 2 diabetes HbA1c lowering less than expected, but researchers note side-effect profile and injection frequency are attractive features 2011 Eye Care Supplement: Eye Infections Current management strategies and key counselling tips. Tighten control of opioids, ICES urges Author drafting new guidelines doubts restrictions, including on opioids marketing, would reduce diversion First Previous 1032 1033 1034 1035 1036 Next Last
